ky1005
Small moleculeexperimental
Clinical trial activity
20 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
15
Phase 3
4
Phase 4
0
Earliest trial started May 1, 2017 (NCT03161288)
Timeline
Indications
Mechanism of action
TNFSF4 inhibitor
- Serine/threonine-protein kinase mTORINHIBITOR
MTOR inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594569 ↗
Also known as
- ky1005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07146750 | Phase 1 | Aug 25, 2025 | Sanofi |
| NCT06686628 | Phase 1 | Nov 13, 2024 | Sanofi |
| NCT06557772 | Phase 2 | Aug 29, 2024 | Sanofi |
| NCT06444451 | Phase 2 | Jun 6, 2024 | Sanofi |
| NCT06407934 | Phase 3 | May 8, 2024 | Sanofi |
| NCT06195072 | Phase 2 | Apr 15, 2024 | Boehringer Ingelheim, Sanofi, Scleroderma Research Foundation, Inc. |
| NCT06224348 | Phase 3 | Jan 18, 2024 | Sanofi |
| NCT06181435 | Phase 3 | Dec 27, 2023 | Sanofi |
| NCT06130566 | Phase 3 | Nov 8, 2023 | Sanofi |
| NCT06118099 | Phase 2 | Nov 1, 2023 | Sanofi |
| NCT06015308 | Phase 2 | Oct 6, 2023 | Sanofi |
| NCT06033833 | Phase 2 | Sep 5, 2023 | Sanofi |
| NCT05769777 | Phase 2 | Apr 3, 2023 | Sanofi |
| NCT05492578 | Phase 2 | Aug 22, 2022 | Sanofi |
| NCT05421598 | Phase 2 | Jun 30, 2022 | Sanofi |
| NCT05796479 | Phase 1 | Apr 28, 2022 | Sanofi |
| NCT05131477 | Phase 2 | Dec 7, 2021 | Kymab Limited, Sanofi |
| NCT04449939 | Phase 1 | Jul 7, 2020 | Hammersmith Medicines Research, Kymab Limited |
| NCT03754309 | Phase 2 | Dec 13, 2018 | Kymab Limited, Universitaetsklinikum Schleswig-Holstein |
| NCT03161288 | Phase 1 | May 1, 2017 | Kymab Limited |
Showing 20 of 20 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 17 | 15 | 3 | 2021 |
| Kymab Limited | For profit | 4 | 4 | 2 | 2017 |
| Boehringer Ingelheim | For profit | 1 | 0 | 1 | 2024 |
| Hammersmith Medicines Research | For profit | 1 | 0 | 1 | 2020 |
| Scleroderma Research Foundation, Inc. | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Universitaetsklinikum Schleswig-Holstein | Academic/Hospital | 1 | 0 | 1 | 2018 |
6 organizations
Page 1 / 1